Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation
Journal of Medicinal Chemistry2012Vol. 55(7), pp. 3285–3306
Citations Over TimeTop 10% of 2012 papers
Richard A. Ward, C. Brassington, Alexander L. Breeze, Alessandro T. Caputo, Susan E. Critchlow, Gareth M. Davies, Louise Goodwin, G. Hassall, Ryan Greenwood, Geoffrey A. Holdgate, Michael Mrosek, Richard A. Norman, Stuart E. Pearson, Jonathan Tart, Julie A. Tucker, Martin Vogtherr, David Whittaker, Jonathan Wingfield, Jon Winter, Kevin Hudson
Abstract
Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate, utilizing NADH as a cofactor. It has been identified as a potential therapeutic target in the area of cancer metabolism. In this manuscript we report our progress using fragment-based lead generation (FBLG), assisted by X-ray crystallography to develop small molecule LDHA inhibitors. Fragment hits were identified through NMR and SPR screening and optimized into lead compounds with nanomolar binding affinities via fragment linking. Also reported is their modification into cellular active compounds suitable for target validation work.
Related Papers
- → Perceiving exterior letters of words: Differential influences of letter-fragment and non-letter-fragment masks.(1995)32 cited
- → The Jewish–Christian Dialogue Jason and Papiscus in Light of the Sinaiticus Fragment(2021)3 cited
- → A FRAGMENT ON DIFFERENCE(2004)2 cited
- → Several commemts on a Genizah fragment of Bavli Eruvin 56a-b, 57a(2018)
- → Fragment-Based Strategies(2013)